Table 2.
SF-12 scores among participants with chronic kidney disease
| PCS Mean ± SE | MCS Mean ± SE | |
|---|---|---|
|
Unadjusted model |
|
|
| No chronic kidney disease (ref) |
40.2 ± 0.6 |
41.1 ± 0.7 |
| Chronic kidney disease (n = 94) |
|
|
| Stage 1 or 2 (n = 58) |
38.6 ± 1.3 |
43.0 ± 1.2 |
| Stage 3 (n = 26) |
34.9 ± 2.0 |
45.6 ± 1.7 |
| Stage 4 (n = 6) |
29.2 ± 2.0 |
32.9 ± 6.2 |
| Stage 5 (n = 4) |
27.6 ± 2.2 |
23.3 ± 4.2 |
|
Adjusted model* |
|
|
| No chronic kidney disease (ref) |
|
|
| Chronic kidney disease |
39.8 ± 0.5 |
40.9 ± 0.7 |
| Stage 1 or 2 |
|
|
| Stage 3 |
39.1 ± 1.1 |
43.3 ± 1.4 |
| Stage 4 |
36.6 ± 1.8 |
Up |
| Stage 5 | 32.2 ± 3.5 | 34.6 ± 4.6 |
Values in bold are significantly different from the referent category. *Adjusted for insulin resistance, and residual effects of age and gender. Stages are based on the National Kidney Foundation/Kidney Disease Outcomes Quality Initiative definition of chronic kidney disease. Abbreviations: PCS: New England Medical Center Physical Health Score, MCS: Mental Health Score, SE: standard error.